HIV treatment bulletin

RSS Atom • ISSN 1472-4683 • Subscribe • About

6th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV (IWADRLH) 26-28 October 2004, Washington

• 6th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV (IWADRLH) 26-28 October 2004, Washington Conference reports - Conference index - Lipodystrophy Workshop (IWADRW) 6 Washington 2004 - 31 January 2005

• Nucleoside analogue-related mitochondrial toxicity and link to lipoatrophy: effect of non-thymidine analogues abacavir and tenofovir Conference reports - Lipodystrophy and metabolic complications - Side effects - Lipodystrophy Workshop (IWADRW) 6 Washington 2004 - 31 January 2005

• Nucleosides reduce PPAR-gamma: a role for rosiglitazone without thymidine analogues? Conference reports - Lipodystrophy Workshop (IWADRW) 6 Washington 2004 - 31 January 2005

• Potential for uridine to treat mitochondrial toxicity: still only in vitro data Conference reports - Lipodystrophy and metabolic complications - Side effects - Lipodystrophy Workshop (IWADRW) 6 Washington 2004 - 31 January 2005

• 25% patients take Kaletra on an empty stomach: dietary advice often missed at 'centre of excellence' Antiretrovirals - Conference reports - Lipodystrophy Workshop (IWADRW) 6 Washington 2004 - 31 January 2005

• rHGH reduces central fat accumulation in adolescent lipodystrophy Conference reports - Lipodystrophy and metabolic complications - Side effects - Lipodystrophy Workshop (IWADRW) 6 Washington 2004 - 31 January 2005

• Weight loss is associated with elevated PBMC proviral DNA levels Basic science and immunology - Conference reports - Lipodystrophy Workshop (IWADRW) 6 Washington 2004 - 31 January 2005

• Coronary artery bypass graft is safe in HIV-positive patients but shows higher risk of longer term events Conference reports - Other news - Lipodystrophy Workshop (IWADRW) 6 Washington 2004 - 31 January 2005

• Endothelial dysfunction similar in ARV-experienced and -naive patients Conference reports - Side effects - Lipodystrophy Workshop (IWADRW) 6 Washington 2004 - 31 January 2005

• Pravastatin improves lipid profiles but not endothelial function Conference reports - Lipodystrophy and metabolic complications - Side effects - Lipodystrophy Workshop (IWADRW) 6 Washington 2004 - 31 January 2005

• Indinavir impairs endothelial function without insulin resistance Antiretrovirals - Conference reports - Lipodystrophy Workshop (IWADRW) 6 Washington 2004 - 31 January 2005

• Treatment interruptions improve lipids within four weeks: IL-2 has no metabolic effect Conference reports - Lipodystrophy and metabolic complications - Side effects - Lipodystrophy Workshop (IWADRW) 6 Washington 2004 - 31 January 2005

• Improvement of lipids following switch to tenofovir Conference reports - Lipodystrophy and metabolic complications - Side effects - Lipodystrophy Workshop (IWADRW) 6 Washington 2004 - 31 January 2005

• HCV coinfection linked to discontinuing ART due to toxicity Conference reports - Hepatitis coinfection - Lipodystrophy Workshop (IWADRW) 6 Washington 2004 - 31 January 2005

• Restorative treatments for HIV-associated lipoatrophy Conference reports - Lipodystrophy and metabolic complications - Side effects - Lipodystrophy Workshop (IWADRW) 6 Washington 2004 - 31 January 2005